DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 6401 - 6425 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▲ Gene Name UniProt ID
C3665349 Secondary hypothyroidism HJV 148738 hemojuvelin BMP co-receptor Q6ZVN8
C0006142 Malignant neoplasm of breast HJV 148738 hemojuvelin BMP co-receptor Q6ZVN8
C0271623 Hypogonadotropic hypogonadism HJV 148738 hemojuvelin BMP co-receptor Q6ZVN8
C0268059 Neonatal hemochromatosis HJV 148738 hemojuvelin BMP co-receptor Q6ZVN8
C3665347 Visual Impairment B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0027092 Myopia B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0026850 Muscular Dystrophy B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0018784 Sensorineural Hearing Loss (disorder) B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0854723 Retinal Dystrophies B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0241005 Creatine phosphokinase serum increased B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C3554638 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11 B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0086543 Cataract B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0699743 Congenital muscular dystrophy (disorder) B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0265221 Walker-Warburg congenital muscular dystrophy B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0678222 Breast Carcinoma B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0456909 Blindness B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0036857 Severe intellectual disability B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0006826 Malignant Neoplasms B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C3714756 Intellectual Disability B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0013384 Dyskinetic syndrome B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0751495 Seizures, Focal B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0029124 Optic Atrophy B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0010417 Cryptorchidism B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0037822 Speech Disorders B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0
C0266483 Pachygyria B3GALNT2 148789 beta-1,3-N-acetylgalactosaminyltransferase 2 Q8NCR0

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024